19 April 2022: Clinical Research
Factors Associated with Non-Adherence for Prescribed Treatment in 201 Patients with Multidrug-Resistant and Rifampicin-Resistant Tuberculosis in Anhui Province, China
Qing-Qing Zhu 1BCDE* , Jie Wang 23BCDE* , Napoleon Bellua Sam 4F , Jie Luo 5F , Jie Liu 1A* , Hai-Feng Pan 23A*DOI: 10.12659/MSM.935334
Med Sci Monit 2022; 28:e935334
Table 3 Univariate analysis of influencing factors for multidrug-resistant tuberculosis and rifampicin-resistant tuberculosis non-adherence and odds ratio value with 95% CI of each variable.
| Odds ratio | 95% confidence interval | |
|---|---|---|
| Yes | – | – |
| No | 0.401 | 0.203–0.791 |
| Yes | – | – |
| No | 0.040 | 0.018–0.091 |
| Primary and below | 1.0 | – |
| Middle and high | 0.443 | 0.227–0.865 |
| Junior college and above | 0.105 | 0.023–0.482 |
| City | 1.0 | – |
| County | 3.782 | 1.562–9.161 |
| Countryside | 2.669 | 1.288–5.530 |
| 316 and below | 1.0 | – |
| 316–790 | 0.302 | 0.149–0.612 |
| Over 790 | 0.176 | 0.062–0.496 |
| 0 | 1.0 | – |
| 1 | 1.172 | 0.227–6.050 |
| 2 | 5.409 | 1.132–25.844 |
| Over 2 | 5.368 | 1.137–25.337 |